Kennedy RB - Search Results

1

Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia.

Passerini M, Ratishvili T, Monroe JM, Temesgen Z, Witzig TE, Kay NE, Kennedy RB, Parikh SA. Passerini M, et al. Among authors: kennedy rb. Leuk Lymphoma. 2023 Apr;64(4):874-883. doi: 10.1080/10428194.2023.2183730. Epub 2023 Mar 12. Leuk Lymphoma. 2023. PMID: 36908110

2

The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).

Whitaker JA, Parikh SA, Shanafelt TD, Kay NE, Kennedy RB, Grill DE, Goergen KM, Call TG, Kendarian SS, Ding W, Poland GA. Whitaker JA, et al. Among authors: kennedy rb. Vaccine. 2021 Feb 12;39(7):1122-1130. doi: 10.1016/j.vaccine.2021.01.001. Epub 2021 Jan 16. Vaccine. 2021. PMID: 33461835 Free PMC article.

3

Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

Muchtar E, Koehler AB, Johnson MJ, Rabe KG, Ding W, Call TG, Leis JF, Kenderian SS, Hayman SR, Wang Y, Hampel PJ, Holets MA, Darby HC, Slager SL, Kay NE, Miao C, Canniff J, Whitaker JA, Levin MJ, Schmid DS, Kennedy RB, Weinberg A, Parikh SA. Muchtar E, et al. Among authors: kennedy rb. Am J Hematol. 2022 Jan 1;97(1):90-98. doi: 10.1002/ajh.26388. Epub 2021 Nov 5. Am J Hematol. 2022. PMID: 34699616 Free PMC article.

4

Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination.

Haralambieva IH, Monroe JM, Ovsyannikova IG, Grill DE, Poland GA, Kennedy RB. Haralambieva IH, et al. Among authors: kennedy rb. J Infect Dis. 2022 Aug 12;226(1):23-31. doi: 10.1093/infdis/jiac042. J Infect Dis. 2022. PMID: 35137144 Free PMC article.

5

The Influence of Sex, Body Mass Index, and Age on Cellular and Humoral Immune Responses Against Measles After a Third Dose of Measles-Mumps-Rubella Vaccine.

Quach HQ, Chen J, Monroe JM, Ratishvili T, Warner ND, Grill DE, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB. Quach HQ, et al. Among authors: kennedy rb. J Infect Dis. 2022 Dec 28;227(1):141-150. doi: 10.1093/infdis/jiac351. J Infect Dis. 2022. PMID: 35994504 Free PMC article.

6

Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection.

Monroe JM, Haralambieva IH, Warner ND, Grill DE, Quach HQ, Kennedy RB. Monroe JM, et al. Among authors: kennedy rb. Heliyon. 2022 Nov 19;8(11):e11676. doi: 10.1016/j.heliyon.2022.e11676. eCollection 2022 Nov. Heliyon. 2022. PMID: 36439767 Free PMC article.

7

Vertical Transmission of SARS-CoV-2-Specific Antibodies and Cytokine Profiles in Pregnancy.

Monroe JM, Quach HQ, Punia S, Enninga EAL, Fedyshyn Y, Girsch JH, Fedyshyn B, Lemens M, Littlefield D, Behl S, Sintim-Aboagye E, Mejia Plazas MC, Yamaoka S, Ebihara H, Pandey A, Correia C, Ung CY, Li H, Vassallo R, Sun J, Johnson EL, Olson JE, Theel ES, Badley AD, Kennedy RB, Theiler RN, Chakraborty R. Monroe JM, et al. Among authors: kennedy rb. J Infect Dis. 2024 Feb 14;229(2):473-484. doi: 10.1093/infdis/jiad399. J Infect Dis. 2024. PMID: 37786979

8

A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides.

Ratishvili T, Quach HQ, Haralambieva IH, Suryawanshi YR, Ovsyannikova IG, Kennedy RB, Poland GA. Ratishvili T, et al. Among authors: kennedy rb. Vaccine. 2024 Jan 12;42(2):162-174. doi: 10.1016/j.vaccine.2023.12.024. Epub 2023 Dec 16. Vaccine. 2024. PMID: 38105139

9

Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine.

Haralambieva IH, Monroe JM, Ovsyannikova IG, Warner ND, Grill DE, Poland GA, Kennedy RB. Haralambieva IH, et al. Among authors: kennedy rb. Vaccine. 2024 Feb 6;42(4):912-917. doi: 10.1016/j.vaccine.2024.01.032. Epub 2024 Jan 17. Vaccine. 2024. PMID: 38233288

10

Detection of SARS-CoV-2-Specific Cells Utilizing Whole Proteins and/or Peptides in Human PBMCs Using IFN-ƴ ELISPOT Assay.

Rasche MM, Kaufmann EC, Ratishvili T, Swanson IM, Ovsyannikova IG, Kennedy RB. Rasche MM, et al. Among authors: kennedy rb. Methods Mol Biol. 2024;2768:117-133. doi: 10.1007/978-1-0716-3690-9_8. Methods Mol Biol. 2024. PMID: 38502391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page